From October 1, 2022 to December 31, 2022, the company has repurchased 827,300 shares, representing 0.1% for CNY 31.5 million. With this, the company has completed the repurchase of 1,257,300 shares, representing 0.15% for CNY 47.3 million under the buyback announced on September 1, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.57 CNY | +1.80% |
|
+4.63% | -43.95% |
24/05 | Tranche Update on Zhejiang Jiuzhou Pharmaceutical Co., Ltd's Equity Buyback Plan announced on January 5, 2024. | CI |
23/05 | Jiuzhou Pharmaceutical Plans CRO in Germany | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.95% | 165.06Cr | |
+55.35% | 85TCr | |
+31.64% | 63TCr | |
-0.10% | 36TCr | |
+15.47% | 32TCr | |
+13.10% | 30TCr | |
+15.51% | 24TCr | |
+16.72% | 23TCr | |
+16.54% | 18TCr | |
+4.31% | 17TCr |
- Stock Market
- Equities
- 603456 Stock
- News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Tranche Update on Zhejiang Jiuzhou Pharmaceutical Co., Ltd's Equity Buyback Plan announced on September 1, 2022.